-
2
-
-
79959851207
-
Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: High number of uncaptured cases by cancer registries
-
Cogle CR, Craig BM, Rollison DE, et al . Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries . Blood 2011 ; 117 : 7121-7125 .
-
(2011)
Blood
, vol.117
, pp. 7121-7125
-
-
Cogle, C.R.1
Craig, B.M.2
Rollison, D.E.3
-
3
-
-
79952362122
-
Copy number alterations at polymorphic loci may be acquired somatically in patients with myelodysplastic syndromes
-
Starczynowski DT, Vercauteren S, Sung S, et al . Copy number alterations at polymorphic loci may be acquired somatically in patients with myelodysplastic syndromes . Leuk Res 2011; 35: 444-447.
-
(2011)
Leuk Res
, vol.35
, pp. 444-447
-
-
Starczynowski, D.T.1
Vercauteren, S.2
Sung, S.3
-
4
-
-
54049105351
-
High-resolution whole genome tiling path array CGH analysis of CD34-cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival
-
Starczynowski DT, Vercauteren S, Telenius A, et al . High-resolution whole genome tiling path array CGH analysis of CD34-cells from patients with low-risk myelodysplastic syndromes reveals cryptic copy number alterations and predicts overall and leukemia-free survival . Blood 2008 ; 112 : 3412-3424 .
-
(2008)
Blood
, vol.112
, pp. 3412-3424
-
-
Starczynowski, D.T.1
Vercauteren, S.2
Telenius, A.3
-
5
-
-
77954468513
-
Array comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities
-
Vercauteren S M, S ung S, S tarczynowski D T, et a l. A rray comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities . Am J Clin Pathol 2010 ; 134 : 119-126 .
-
(2010)
Am J Clin Pathol
, vol.134
, pp. 119-126
-
-
Vercauteren, S.M.1
Sung, S.2
Starczynowski, D.T.3
-
6
-
-
70350720044
-
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
-
Figueroa ME, Skrabanek L, Li Y, et al . MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation . Blood 2009 ; 114 : 3448-3458 .
-
(2009)
Blood
, vol.114
, pp. 3448-3458
-
-
Figueroa, M.E.1
Skrabanek, L.2
Li, Y.3
-
7
-
-
83455234787
-
Clinical signifi cance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
-
Malcovati L, Papaemmanuil E, Bowen DT, et al . Clinical signifi cance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/ myeloproliferative neoplasms . Blood 2011; 118: 6239-6246 .
-
(2011)
Blood
, vol.118
, pp. 6239-6246
-
-
Malcovati, L.1
Papaemmanuil, E.2
Bowen, D.T.3
-
8
-
-
80054010617
-
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts
-
Papaemmanuil E, Cazzola M, Boultwood J, et al . Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts . N Engl J Med 2011 ; 365 : 1384-1395 .
-
(2011)
N Engl J Med
, vol.365
, pp. 1384-1395
-
-
Papaemmanuil, E.1
Cazzola, M.2
Boultwood, J.3
-
9
-
-
84855841586
-
SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value
-
Patnaik MM, Lasho TL, Hodnefi eld JM, et al . SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value . Blood 2012 ; 119 : 569-572 .
-
(2012)
Blood
, vol.119
, pp. 569-572
-
-
Patnaik, M.M.1
Lasho, T.L.2
Hodnefield, J.M.3
-
10
-
-
80053900941
-
Frequent pathway mutations of splicing machinery in myelodysplasia
-
Yoshida K, Sanada M, Shiraishi Y, et al . Frequent pathway mutations of splicing machinery in myelodysplasia . Nature 2011; 478: 64-69.
-
(2011)
Nature
, vol.478
, pp. 64-69
-
-
Yoshida, K.1
Sanada, M.2
Shiraishi, Y.3
-
11
-
-
59149102237
-
Target site eff ects in the RNA interference and microRNA pathways
-
Obernosterer G, Tafer H, Martinez J . Target site eff ects in the RNA interference and microRNA pathways . Biochem Soc Trans 2008 ; 36 : 1216-1219 .
-
(2008)
Biochem Soc Trans
, vol.36
, pp. 1216-1219
-
-
Obernosterer, G.1
Tafer, H.2
Martinez, J.3
-
12
-
-
47149109822
-
MicroRNAs in normal and malignant hematopoiesis
-
Garzon R, C roce C M. M icroRNAs in normal and malignant hematopoiesis . Curr Opin Hematol 2008 ; 15 : 352-358 .
-
(2008)
Curr Opin Hematol
, vol.15
, pp. 352-358
-
-
Garzon, R.1
Croce, C.M.2
-
13
-
-
70249129354
-
MicroRNAs in normal and malignant myelopoiesis
-
Pelosi E, Labbaye C, Testa U . MicroRNAs in normal and malignant myelopoiesis . Leuk Res 2009; 33: 1584-1593.
-
(2009)
Leuk Res
, vol.33
, pp. 1584-1593
-
-
Pelosi, E.1
Labbaye, C.2
Testa, U.3
-
14
-
-
80051475292
-
Diagnostic microRNAs in myelodysplastic syndrome
-
Erdogan B, Facey C, Qualtieri J, et al . Diagnostic microRNAs in myelodysplastic syndrome . Exp Hematol 2011 ; 39 : 915-926 .e2.
-
(2011)
Exp Hematol
, vol.39
-
-
Erdogan, B.1
Facey, C.2
Qualtieri, J.3
-
15
-
-
79955945973
-
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies
-
Tiu RV, Gondek LP, O' Keefe CL, et al . Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies . Blood 2011 ; 117 : 4552-4560 .
-
(2011)
Blood
, vol.117
, pp. 4552-4560
-
-
Tiu, R.V.1
Gondek, L.P.2
O'Keefe, C.L.3
-
16
-
-
6344281172
-
Identifi cation of mammalian microRNA host genes and transcription units
-
Rodriguez A, Griffi ths-Jones S, A shurst J L, et a l. I dentifi cation of mammalian microRNA host genes and transcription units . Genome Res 2004; 14: 1902-1910.
-
(2004)
Genome Res
, vol.14
, pp. 1902-1910
-
-
Rodriguez, A.1
Griffiths-Jones, S.2
Ashurst, J.L.3
-
17
-
-
13944260434
-
Microarray profi ling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes
-
Baskerville S, Bartel DP . Microarray profi ling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes . RNA 2005 ; 11 : 241-247 .
-
(2005)
RNA
, vol.11
, pp. 241-247
-
-
Baskerville, S.1
Bartel, D.P.2
-
18
-
-
67049104896
-
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma
-
Ronchetti D, L ionetti M, M osca L, et a l. A n integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma . BMC Med Genomics 2008 ; 1 : 37 .
-
(2008)
BMC Med Genomics
, vol.1
, pp. 37
-
-
Ronchetti, D.1
Lionetti, M.2
Mosca, L.3
-
19
-
-
0001679798
-
Induction of diff erentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid
-
Breitman TR, Selonick SE, Collins SJ . Induction of diff erentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid . Proc Natl Acad Sci USA 1980 ; 77 : 2936-2940 .
-
(1980)
Proc Natl Acad Sci USA
, vol.77
, pp. 2936-2940
-
-
Breitman, T.R.1
Selonick, S.E.2
Collins, S.J.3
-
20
-
-
59149089005
-
Role of microRNAs in myeloid diff erentiation
-
Fatica A, Rosa A, Ballarino M, et al . Role of microRNAs in myeloid diff erentiation . Biochem Soc Trans 2008 ; 36 : 1201-1205 .
-
(2008)
Biochem Soc Trans
, vol.36
, pp. 1201-1205
-
-
Fatica, A.1
Rosa, A.2
Ballarino, M.3
-
21
-
-
70349249936
-
Microarray-based classifi ers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome
-
Mills K I, K ohlmann A, W illiams P M, et a l. M icroarray-based classifi ers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome . Blood 2009 ; 114 : 1063-1072 .
-
(2009)
Blood
, vol.114
, pp. 1063-1072
-
-
Mills, K.I.1
Kohlmann, A.2
Williams, P.M.3
-
22
-
-
21044439177
-
Approval summary: Azacitidine for treatment of myelodysplastic syndrome subtypes
-
Kaminskas E, Farrell A, Abraham S, et al . Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes . Clin Cancer Res 2005; 11: 3604-3608.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 3604-3608
-
-
Kaminskas, E.1
Farrell, A.2
Abraham, S.3
-
23
-
-
33646071894
-
Decitabine improves patient outcomes in myelodysplastic syndromes: Results of a phase III randomized study
-
Kantarjian H, Issa JP, Rosenfeld CS, et al . Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study . Cancer 2006 ; 106 : 1794-1803 .
-
(2006)
Cancer
, vol.106
, pp. 1794-1803
-
-
Kantarjian, H.1
Issa, J.P.2
Rosenfeld, C.S.3
-
24
-
-
33947281469
-
Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: Comparison with historical experience
-
Kantarjian HM, O' Brien S, Huang X, et al . Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience . Cancer 2007 ; 109 : 1133-1137 .
-
(2007)
Cancer
, vol.109
, pp. 1133-1137
-
-
Kantarjian, H.M.1
O'Brien, S.2
Huang, X.3
-
25
-
-
33748474416
-
Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: Studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B
-
Silverman L R, M cKenzie D R, P eterson B L, et a l. F urther analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B . J Clin Oncol 2006 ; 24 : 3895-3903 .
-
(2006)
J Clin Oncol
, vol.24
, pp. 3895-3903
-
-
Silverman, L.R.1
McKenzie, D.R.2
Peterson, B.L.3
-
26
-
-
84860767817
-
SF3B1 mutations in myelodysplastic syndromes: Clinical associations and prognostic implications
-
Damm F, Th ol F, Kosmider O, et al . SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications . Leukemia 2012; 26: 1137-1140.
-
(2012)
Leukemia
, vol.26
, pp. 1137-1140
-
-
Damm, F.1
Thol, F.2
Kosmider, O.3
-
27
-
-
84887246728
-
The role of haploinsuffi ciency of RPS14 and p53 activation in the molecular pathogenesis of the 5q-syndrome
-
Boultwood J . The role of haploinsuffi ciency of RPS14 and p53 activation in the molecular pathogenesis of the 5q-syndrome . Pediatr Rep 2011; 3(Suppl. 2): e10.
-
(2011)
Pediatr Rep
, vol.3
, Issue.SUPPL. 2
-
-
Boultwood, J.1
-
28
-
-
70349643737
-
Low RPS14 expression is common in myelodysplastic syndromes without 5q-aberration and defi nes a subgroup of patients with prolonged survival
-
Czibere A, Bruns I, Junge B, et al . Low RPS14 expression is common in myelodysplastic syndromes without 5q-aberration and defi nes a subgroup of patients with prolonged survival . Haematologica 2009 ; 94 : 1453-1455 .
-
(2009)
Haematologica
, vol.94
, pp. 1453-1455
-
-
Czibere, A.1
Bruns, I.2
Junge, B.3
-
29
-
-
38349088899
-
Identifi cation of RPS14 as a 5qsyndrome gene by RNA interference screen
-
Ebert BL, Pretz J, Bosco J, et al . Identifi cation of RPS14 as a 5qsyndrome gene by RNA interference screen . Nature 2008 ; 451 : 335-339 .
-
(2008)
Nature
, vol.451
, pp. 335-339
-
-
Ebert, B.L.1
Pretz, J.2
Bosco, J.3
-
30
-
-
44649092154
-
Haploinsufficiency of RPS14 in 5q-syndrome is associated with deregulation of ribosomal-and translation-related genes
-
Pellagatti A, H ellstrom-Lindberg E, G iagounidis A, et a l. Haploinsuffi ciency of RPS14 in 5q-syndrome is associated with deregulation of ribosomal-and translation-related genes . Br J Haematol 2008 ; 142 : 57-64 .
-
(2008)
Br J Haematol
, vol.142
, pp. 57-64
-
-
Pellagatti, A.1
Hellstrom-Lindberg, E.2
Giagounidis, A.3
-
31
-
-
1642371165
-
Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells
-
Zhang C C, L odish H F. I nsulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells . Blood 2004 ; 103 : 2513-2521 .
-
(2004)
Blood
, vol.103
, pp. 2513-2521
-
-
Zhang, C.C.1
Lodish, H.F.2
-
32
-
-
46649097230
-
Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer
-
Murrell A, I to Y, V erde G, et a l. D istinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer . PloS One 2008 ; 3 : e1849 .
-
(2008)
PloS One
, vol.3
-
-
Murrell, A.1
Ito, Y.2
Verde, G.3
-
33
-
-
0037396541
-
Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders
-
Bock O, S chlue J, K reipe H . R educed expression of H19 in bone marrow cells from chronic myeloproliferative disorders . Leukemia 2003 ; 17 : 815-816 .
-
(2003)
Leukemia
, vol.17
, pp. 815-816
-
-
Bock, O.1
Schlue, J.2
Kreipe, H.3
-
34
-
-
0036215814
-
Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells
-
Hofmann WK, Takeuchi S, Frantzen MA, et al . Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells . Exp Hematol 2002 ; 30 : 318-323 .
-
(2002)
Exp Hematol
, vol.30
, pp. 318-323
-
-
Hofmann, W.K.1
Takeuchi, S.2
Frantzen, M.A.3
-
35
-
-
0034329247
-
Imprinting of insulinlike growth factor 2 is modulated during hematopoiesis
-
Morison IM, Eccles MR, Reeve AE . Imprinting of insulinlike growth factor 2 is modulated during hematopoiesis . Blood 2000 ; 96 : 3023-3028 .
-
(2000)
Blood
, vol.96
, pp. 3023-3028
-
-
Morison, I.M.1
Eccles, M.R.2
Reeve, A.E.3
-
36
-
-
22344452178
-
Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern
-
Tessema M, Langer F, Bock O, et al . Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern. Int J Oncol 2005; 26: 499-507.
-
(2005)
Int J Oncol
, vol.26
, pp. 499-507
-
-
Tessema, M.1
Langer, F.2
Bock, O.3
-
37
-
-
79957926724
-
WWP2 is an E3 ubiquitin ligase for PTEN
-
Maddika S, Kavela S, Rani N, et al . WWP2 is an E3 ubiquitin ligase for PTEN . Nat Cell Biol 2011 ; 13 : 728-733 .
-
(2011)
Nat Cell Biol
, vol.13
, pp. 728-733
-
-
Maddika, S.1
Kavela, S.2
Rani, N.3
-
38
-
-
79957865731
-
Biochemical analysis of the human ENA/VASP-family proteins, MENA, VASP and EVL, in homologous recombination
-
Takaku M, U eno H, K urumizaka H . B iochemical analysis of the human ENA/VASP-family proteins, MENA, VASP and EVL, in homologous recombination. J Biochem 2011; 149: 721-729.
-
(2011)
J Biochem
, vol.149
, pp. 721-729
-
-
Takaku, M.1
Ueno, H.2
Kurumizaka, H.3
-
39
-
-
77953807425
-
Alterations in the mitochondrial regulatory pathways constituted by the nuclear cofactors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes
-
Zorzano A, Hernandez-Alvarez MI, Palacin M, et al . Alterations in the mitochondrial regulatory pathways constituted by the nuclear cofactors PGC-1alpha or PGC-1beta and mitofusin 2 in skeletal muscle in type 2 diabetes . Biochim Biophys Acta 2010 ; 1797 : 1028-1033 .
-
(2010)
Biochim Biophys Acta
, vol.1797
, pp. 1028-1033
-
-
Zorzano, A.1
Hernandez-Alvarez, M.I.2
Palacin, M.3
-
40
-
-
84872978640
-
MicroRNAs in myelodysplastic syndromes: How much do we know and not know
-
Chen C . microRNAs in myelodysplastic syndromes: how much do we know and not know Leuk Res 2013 ; 37 : 241-242 .
-
(2013)
Leuk Res
, vol.37
, pp. 241-242
-
-
Chen, C.1
|